Ampersand Capital Partners M&A Summary
In the last 3 years, Ampersand Capital Partners has acquired 13 companies. It has also invested in 8 others.
In the last 3 years, Ampersand Capital Partners has exited 9 companies. The Firm’s most common exit type is trade sale (70%). Ampersand Capital Partners’ largest (disclosed) exit occurred in 2008 when it sold Talecris Biotherapeutics Holdings Corp for $3.1B.
Sign-up to view Ampersand Capital Partners’ full profile and discover more large growth capital firm investors just like it.
M&A Summary
-
M&A Total Activity141
- M&A Buy Activity85
- M&A Sell Activity56
- M&A Buy/Sell Connections65
Unlimited Searches
